X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
council aml11 trial (63) 63
index medicus (62) 62
humans (60) 60
aged (57) 57
middle aged (51) 51
acute myelogenous leukemia (41) 41
female (40) 40
male (38) 38
hematology (37) 37
oncology (35) 35
aged, 80 and over (34) 34
treatment outcome (30) 30
elderly-patients (29) 29
leukemia, myeloid, acute - drug therapy (27) 27
prognosis (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
remission induction (24) 24
acute myeloid leukemia (22) 22
adult (22) 22
colony-stimulating factor (22) 22
leukemia, myeloid, acute - mortality (22) 22
southwest-oncology-group (22) 22
older patients (21) 21
age factors (20) 20
acute disease (18) 18
survival rate (17) 17
risk myelodysplastic syndrome (16) 16
abridged index medicus (15) 15
chemotherapy (15) 15
disease-free survival (15) 15
cytarabine - administration & dosage (14) 14
intensive chemotherapy (14) 14
leukemia, myeloid, acute - therapy (14) 14
leukemia, myeloid - drug therapy (13) 13
low-dose cytarabine (13) 13
cancer (12) 12
survival analysis (12) 12
induction chemotherapy (11) 11
acute nonlymphocytic leukemia (10) 10
adolescent (10) 10
antineoplastic agents - therapeutic use (10) 10
remission-induction chemotherapy (10) 10
risk factors (10) 10
elderly patients (9) 9
leukemia, myeloid - mortality (9) 9
leukemia, myeloid, acute - diagnosis (9) 9
leukemia, myeloid, acute - genetics (9) 9
leukemia, myeloid, acute - pathology (9) 9
retrospective studies (9) 9
stem-cell transplantation (9) 9
time factors (9) 9
treatment outcomes (9) 9
aml (8) 8
cooperative-oncology-group (8) 8
cytogenetics (8) 8
elderly (8) 8
follow-up studies (8) 8
gemtuzumab ozogamicin (8) 8
high-dose cytarabine (8) 8
survival (8) 8
cytosine-arabinoside (7) 7
leukemia, myeloid - genetics (7) 7
randomized phase-iii (7) 7
1st complete remission (6) 6
acute myeloid-leukemia (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
chromosome aberrations (6) 6
comorbidity (6) 6
group-b (6) 6
idarubicin - administration & dosage (6) 6
karyotyping (6) 6
leukemia, myeloid, acute - epidemiology (6) 6
myelodysplastic syndrome (6) 6
postremission therapy (6) 6
predictive value of tests (6) 6
transplantation, homologous (6) 6
vidarabine - analogs & derivatives (6) 6
adults (5) 5
age (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
bone-marrow-transplantation (5) 5
clinical trials and observations (5) 5
clinical trials as topic (5) 5
european organization (5) 5
leukemia, myeloid - therapy (5) 5
leukocyte count (5) 5
oncology-group (5) 5
prognostic-factors (5) 5
prospective studies (5) 5
research (5) 5
trans-retinoic acid (5) 5
acute myeloid leukaemia (4) 4
adult patients (4) 4
antimetabolites, antineoplastic - administration & dosage (4) 4
care and treatment (4) 4
cytarabine (4) 4
cytarabine - therapeutic use (4) 4
daunorubicin - administration & dosage (4) 4
dose-response relationship, drug (4) 4
etoposide - administration & dosage (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 24, Issue 3, pp. 444 - 453
Journal Article
Journal Article